CD19-Targeted Immunotherapy Attenuates Vessel Wall Inflammation

被引：4
|
作者：
Derlin, Thorsten [1 ]
Koenecke, Christian [1 ]
Schultze-Florey, Christian [1 ]
Ganser, Arnold [1 ]
Bengel, Frank M. [1 ]
机构：
[1] Hannover Med Sch, Dept Nucl Med, Carl Neuberg Str 1, D-30625 Hannover, Germany
来源：
JACC-CARDIOVASCULAR IMAGING | 2021年 / 14卷 / 09期
关键词：
D O I：
10.1016/j.jcmg.2021.02.025
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1864 / 1866
页数：3
相关论文
共 50 条
  • [21] Neurotoxicity Associated with CD19-Targeted CAR-T Cell Therapies
    Gust, Juliane
    Taraseviciute, Agne
    Turtle, Cameron J.
    CNS DRUGS, 2018, 32 (12) : 1091 - 1101
  • [22] Late Effects of CD19-Targeted CAR-T Cell Therapy
    Cordeiro, Ana
    Bezerra, Evandro D.
    Hill, Joshua Aiden
    Turtle, Cameron J.
    Maloney, David G.
    Bar, Merav
    BLOOD, 2018, 132
  • [23] Neurotoxicity Associated with CD19-Targeted CAR-T Cell Therapies
    Juliane Gust
    Agne Taraseviciute
    Cameron J. Turtle
    CNS Drugs, 2018, 32 : 1091 - 1101
  • [24] CD19-Targeted CAR T Cells as Novel Cancer Immunotherapy for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
    Davila, Marco L.
    Brentjens, Renier J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (10) : 802 - 808
  • [25] Are we ready for CD19-targeted CAR T-cell therapies in MS?
    Giovannoni, Gavin
    Hawkes, Christopher H.
    Lechner-Scott, Jeannette
    Levy, Michael
    Yeh, E. Ann
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 70
  • [26] A novel polymer-conjugated human IL-15 improves efficacy of CD19-targeted CAR T-cell immunotherapy
    Hirayama, Alexandre, V
    Chou, Cassie K.
    Miyazaki, Takahiro
    Steinmetz, Rachel N.
    Di, Henna A.
    Fraessle, Simon P.
    Gauthier, Jordan
    Fiorenza, Salvatore
    Hawkins, Reed M.
    Overwijk, Willem W.
    Riddell, Stanley R.
    Marcondes, Mario Q.
    Turtle, Cameron J.
    BLOOD ADVANCES, 2023, 7 (11) : 2479 - 2493
  • [27] Circulating CD19-Negative CD22-Positive Progenitor Population: A Diagnostic Pitfall for Minimal Residual Disease Detection in B-Lymphoblastic Leukemia Post CD19-Targeted Immunotherapy
    Zhou, Ting
    Yuan, Constance
    Stetler-Stevenson, Maryalice
    Wang, Hao-Wei
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 913 - 915
  • [28] Circulating CD19-Negative CD22-Positive Progenitor Population: A Diagnostic Pitfall for Minimal Residual Disease Detection in B-Lymphoblastic Leukemia Post CD19-Targeted Immunotherapy
    Zhou, Ting
    Yuan, Constance
    Stetler-Stevenson, Maryalice
    Wang, Hao-Wei
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 913 - 915
  • [29] Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
    Fraietta, Joseph A.
    Nobles, Christopher L.
    Sammons, Morgan A.
    Lundh, Stefan
    Carty, Shannon A.
    Reich, Tyler J.
    Cogdill, Alexandria P.
    Morrissette, Jennifer J. D.
    DeNizio, Jamie E.
    Reddy, Shantan
    Hwang, Young
    Gohil, Mercy
    Kulikovskaya, Irina
    Nazimuddin, Farzana
    Gupta, Minnal
    Chen, Fang
    Everett, John K.
    Alexander, Katherine A.
    Lin-Shiao, Enrique
    Gee, Marvin H.
    Liu, Xiaojun
    Young, Regina M.
    Ambrose, David
    Wang, Yan
    Xu, Jun
    Jordan, Martha S.
    Marcucci, Katherine T.
    Levine, Bruce L.
    Garcia, K. Christopher
    Zhao, Yangbing
    Kalos, Michael
    Porter, David L.
    Kohli, Rahul M.
    Lacey, Simon F.
    Berger, Shelley L.
    Bushman, Frederic D.
    June, Carl H.
    Melenhorst, J. Joseph
    NATURE, 2018, 558 (7709) : 307 - +
  • [30] Serial evaluation of CD19 surface expression in pediatric B-cell malignancies following CD19-targeted therapy
    Libert, Diane
    Yuan, Constance M.
    Masih, Katherine E.
    Galera, Pallavi
    Salem, Dalia
    Shalabi, Haneen
    Yates, Bonnie
    Delbrook, Cindy
    Shern, Jack F.
    Fry, Terry J.
    Khan, Javed
    Stetler-Stevenson, Maryalice
    Shah, Nirali N.
    LEUKEMIA, 2020, 34 (11) : 3064 - 3069
12345